Navigation Links
Parker Waichman LLP Commends Arkansas Attorney General for Backing Fine Against Johnson & Johnson over Risperdal Off-Label Marketing Allegations
Date:6/21/2013

New York, NY (PRWEB) June 21, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, notes that a number of lawmakers are telling the Arkansas Supreme Court to uphold the $1.2 billion fine imposed on Johnson & Johnson (J&J) by a lower court for off-label marketing claims related to the company’s antipsychotic drug Risperdal, according to a June 18 Associated Press report published on WashingtonPost.com.

As noted in the report, state Attorney General Dustin McDaniel called on the state’s Supreme Court justices to reject J&J’s appeal of the lower court’s ruling in which the drug maker was found to have downplayed and hid risks associated with Risperdal use (State of Arkansas v. Ortho-McNeil-Janssen Pharmaceuticals Inc., case no: CV07-15345). Numerous supporters have emerged to back the lower court’s decision, including 35 state attorneys general, 65 Arkansas lawmakers, as well as former U.S. Food and Drug Administration (FDA) Commissioner Donald Kennedy, the report added.

The allegations that J&J had made off-label marketing claims centered on the company’s effort to prompt doctors to prescribe Risperdal for children before the FDA had approved the drug for use by children, according to an August 30, 2012, Reuters report. The FDA initially approved Risperdal for use by adults, in 1993; it wasn’t approved for children until 1997. As the Reuters article related, drug makers can only legally promote their drugs for FDA-approved uses. Doctors, on the other hand, are free to prescribe a drug for any reason they see fit – when it is for something not approved by the FDA, it is called using the drug “off-label.”

Risperdal is an antipsychotic medication used to treat conditions such as schizophrenia, bipolar disorder and acute mania associated with autistic disorders. It has been linked to side effects such as male breast growth, known as gynecomastia. On April 1, 2006, the Journal of Clinical Psychopharmacology published a report releasing its findings that levels of prolactin – which is the hormone that stimulates milk production – are increased in Risperdal users. Parker Waichman LLP is offering free case evaluations for patients who took Risperdal and suffered from gynecomastia and other unexpected side effects. Symptoms of gynecomastia, as defined by the Mayo Clinic on its website, include:

  •     Swelling
  •     Pain
  •     Tenderness
  •     Nipple discharge in one or both breasts

Parker Waichman LLP continues to offer free lawsuit consultations to victims of Risperdal side effects. If you or a loved one experienced complications following POP and SUI surgery with mesh, please visit the firm's Risperdal Side Effects page at yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636)

Contact: Parker Waichman LLP
                 Gary Falkowitz, Managing Attorney
                 (800) LAW-INFO
                 (800) 529-4636
                 http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/risperdal_arkansas_fine/06/prweb10859554.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. San Bruno, CA Dentist Dr. Bradley Parker Receives Top Reviews for New Laser Assisted Dental Treatments
2. YourPleasurableSecrets.com, a leading retailer of Pipedream Products, Adult Toys & Novelties, is replenishing their lineup of adult movies Kay Parker has starred in.
3. In Light of Alleged Deceptive Marketing Claims Made by Drug Makers, Parker Waichman LLP Addresses Issues Allegedly Related to the Safety and Effectiveness of Plavix
4. Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Responds to Doctor’s Testimony Alleging Intuitive Surgical’s Robotic Device Contributed to a Man’s Death
5. Wisconsin Woman Alleges She was Injured by Transvaginal Mesh Devices in Lawsuit Filed by Parker Waichman LLP
6. Parker Waichman LLP Files Class Action Lawsuit on Behalf of Consumers Who’ve Purchased Azek Decking
7. Texas Woman Alleges Actos Caused her Bladder Cancer, Parker Waichman LLP Files Lawsuit on Victim’s Behalf
8. In Light of New Research Findings, Parker Waichman LLP Warns about Risk of Texting While Driving
9. New York Woman Suffers Injuries Allegedly Due to Boston Scientific’s Transvaginal Mesh Device, Lawsuit Filed by Parker Waichman LLP
10. Missouri Man Alleges Five Years of Actos Use Caused his Bladder Cancer; Parker Waichman LLP Files Lawsuit on Victim’s Behalf
11. Parker Waichman LLP Responds to an Intuitive Surgical Notice that the da Vinci Surgical Robot, Due to a Defect, Can Electrically Burn a Patient During Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... , ... Premier Fitness Camp (PFC) and The Chopra Center for Wellbeing announced ... program, at their world headquarters of Omni La Costa Resort & Spa in San ... seeking weight loss, personal development, a healthy lifestyle, or mental and physical healing. The ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Medical Center has been recognized for adherence to the highest standards of ... medical accreditation organizations, announced the center's president and CEO, Dr. Daniel Messina. , ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into law ... in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition ... to the study, medical payments per claim in California decreased 4 percent in 2013 ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec 9, 2016 Research and ... Market 2016-2020" report to their offering. ... The global travel vaccines market to ... The report covers the present scenario and the growth prospects ... market size, the report considers the revenue generated from the sales ...
(Date:12/8/2016)... Calif. , Dec. 8, 2016 IRIDEX Corporation ... to offer newly issued shares of common stock, $0.01 par ... to an underwritten public offering.  The final terms of the ... time of pricing, and there can be no assurance as ... IRIDEX expects to use the net proceeds it will ...
(Date:12/8/2016)... LONDON , Dec. 8, 2016  The global ... of 8.8% during the forecast period of 2016 to ... billion by 2021 from USD 18.21 billion in 2016. ... surgeries, rising incidences of sports related injuries and spinal ... and rising need of effective blood loss management. ...
Breaking Medicine Technology: